MedPath

Serological Study of the Exposure of Personnel to COVID-19

Not Applicable
Completed
Conditions
Sars-CoV2
Interventions
Diagnostic Test: Sars-Cov-2 serology
Registration Number
NCT04422977
Lead Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Brief Summary

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine:

* whether the subject has shown signs of infection in the last 3 recent months

* if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague)

* Working conditions during the period

* The level of knowledge and respect of the barrier measures practices.

* Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
957
Inclusion Criteria
  • Subject who worked at Saint Joseph Saint Luke's Hospital during the epidemic wave (male or female).

    • Free and informed consent
    • Social security affiliation
Exclusion Criteria
  • Subject refusal
  • Subject on leave during the entire period

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CoVID exposureSars-Cov-2 serology-
Primary Outcome Measures
NameTimeMethod
Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff with a seroconversion test for SARS-Cov-21 month

Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier St Joseph St Luc

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath